Open AccessSuccessful treatment of hepatic oligometastases with stereotactic ablative radiotherapy and radiofrequency ablation in an anaplastic lymphoma kinase fusion‐positive lung cancer patient
Author(s) -
Weber Britta,
Liu Mitchell,
Sobkin Paul,
Morris Stephan W.,
Hout David,
Westhuizen Nicholas,
Tonseth R. Petter,
Saltman David L.
Publication year - 2016
Publication title -
journal of medical radiation sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 18
eISSN - 2051-3909
pISSN - 2051-3895
DOI - 10.1002/jmrs.144
Subject(s) - ablative case , medicine , anaplastic lymphoma kinase , radiofrequency ablation , lung cancer , radiation therapy , radiosurgery , radiology , oncology , cancer , ablation , lymphoma , malignant pleural effusion
Local ablative therapy with stereotactic ablative radiotherapy may improve survival in oncogene‐addicted lung cancer patients with extracranial oligometastatic disease treated with targeted therapies. There is limited data on the use of radiofrequency ablation ( RFA ) in this same setting. We present a case of an anaplastic lymphoma kinase ( ALK )‐positive lung cancer patient with hepatic oligometastatic progression who was successfully treated with both stereotactic ablative radiation and RFA while continuing with an ALK inhibitor.